Kaempferol Improved Rheumatoid Arthritis by Regulating the Immune Imbalance of Treg/Th17

Abstract

Objective

The objective of this study was to explore the therapeutic effects of kaempferol (Kae) on rheumatoid arthritis (RA) and to elucidate the underlying mechanisms.

Methods

The collagen-induced arthritis (CIA) model was established using collagen II to induce RA. Mice were treated with Kae at a dose of 25 or 50 mg/kg/day via gavage. Pathological changes in the ankle joint were analyzed. Enzyme-linked immunosorbent assay (ELISA) was employed to measure the levels of inflammatory factors. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) was used to assess the expression of genes associated with the balance of regulatory T (Treg)/T helper 17 (Th17) cells. Flow cytometry was utilized to determine the Treg/Th17 ratio. Furthermore, these techniques were employed to evaluate the impact of miR-34a and Foxp3 dysregulation on cellular functions in RA under the influence of Kae. Dual luciferase reporter assay was conducted to analyze the binding of miR-34a to Foxp3.

Results

Treatment with Kae led to a downregulation of receptor-related orphan receptor gamma t (RORγt) and IL-17 expression, and an upregulation of Foxp3, IL-10, and TGF-β expression in CIA mice. Kae intervention inhibited the production of proinflammatory cytokines and increased the production of anti-inflammatory cytokines. Furthermore, Kae treatment suppressed the expression of miR-34a, which was identified as a target of miR-34a. Finally, Kae regulated Treg/ Th17 balance-related genes and cellular inflammation through the miR-34a/Foxp3 axis.

Conclusion

The study demonstrated that Kae effectively ameliorates CIA in mice by modulating the Treg/Th17 balance and related genes via the miR-34a/Foxp3 axis. These findings suggest that Kae may serve as a promising therapeutic agent for the treatment of RA and for restoring immune homeostasis.

References

[1] Scherer HU, Häupl T, Burmester GR. The etiology of rheumatoid arthritis. J Autoimmun, 2020, 110: 102400

[2] Huang J, Fu X, Chen X, et al.. Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis. Front Immunol, 2021, 12: 686155

[3] Curtis JR, Emery P, Karis E, et al.. Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission. Arthritis Rheumatol, 2021, 73(5): 759-768

[4] Dong L, Wang X, Tan J, et al.. Decreased expression of microRNA-21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis. J Cell Mol Med, 2014, 18(11): 2213-2224

[5] Stoma AM, Bartosińska J, Raczkiewicz D, et al.. Multiple Cytokine Analysis of Th1/Th2/Th9/Th17/Th22/Treg Cytokine Pathway for Individual Immune Profile Assessment in Patients with Psoriasis. Med Sci Monit, 2022, 28(12): e938277

[6] Najar M, Merimi M, Faour WH, et al.. In Vitro Cellular and Molecular Interplay between Human Foreskin-Derived Mesenchymal Stromal/Stem Cells and the Th17 Cell Pathway. Pharmaceutics, 2021, 13(10): 1736

[7] Hui W, Yu D, Cao Z, et al.. Butyrate inhibit collagen-induced arthritis via Treg/IL-10/Th17 axis. Int Immunopharmacol, 2019, 68(3): 226-233

[8] Gorczynski R, Yu K, Chen Z, et al.. Anti-CD200R2, anti-IL-9, anti-IL-35, or anti-TGF-beta abolishes increased graft survival and Treg induction induced in cromolyn-treated CD200R1KO. CD200tg mice. Transplantation, 2014, 97(1): 39-46

[9] Liu J, Hong X, Lin D, et al.. Artesunate influences Th17/Treg lymphocyte balance by modulating Treg apoptosis and Th17 proliferation in a murine model of rheumatoid arthritis. Exp Ther Med, 2017, 13(5): 2267-2273

[10] Cunningham CC, Wade S, Floudas A, et al.. Serum miRNA Signature in Rheumatoid Arthritis and “At-Risk Individuals”. Front Immunol, 2021, 12(3): 633201

[11] Sharma AR, Sharma G, Lee SS, et al.. miRNA-Regulated Key Components of Cytokine Signaling Pathways and Inflammation in Rheumatoid Arthritis. Med Res Rev, 2016, 36(3): 425-439

[12] Chang C, Xu L, Zhang R, et al.. MicroRNA-Mediated Epigenetic Regulation of Rheumatoid Arthritis Susceptibility and Pathogenesis. Front Immunol, 2022, 3(3): 838884

[13] Jin S, Sun S, Ling H, et al.. Protectin DX restores Treg/T(h)17 cell balance in rheumatoid arthritis by inhibiting NLRP3 inflammasome via miR-20a. Cell Death Dis, 2021, 12(3): 280

[14] Liu M, Ren T, Lin Z, et al.. Upregulated miR-146a Expression in Peripheral Blood Relates to Th17 and Treg Imbalance in Elder Rheumatoid Arthritis Patients. Lifestyle Genom, 2022, 15(3): 98-106

[15] Zhao X, Yi Y, Jiang C, et al.. Gancao Fuzi decoction regulates the Th17/Treg cell imbalance in rheumatoid arthritis by targeting Foxp3 via miR-34a. J Ethnopharmacol, 2023, 301(1): 115837

[16] Yang Y, Chen Z, Zhao X, et al.. Mechanisms of Kaempferol in the treatment of diabetes: A comprehensive and latest review. Front Endocrinol (Lausanne), 2022, 13(9): 990299

[17] Alam W, Khan H, Shah MA, et al.. Kaempferol as a Dietary Anti-Inflammatory Agent: Current Therapeutic Standing. Molecules, 2020, 25(18): 4073

[18] Imran M, Rauf A, Shah ZA, et al.. Chemo-preventive and therapeutic effect of the dietary flavonoid kaempferol: A comprehensive review. Phytother Res, 2019, 33(2): 263-275

[19] Pan D, Li N, Liu Y, et al.. Kaempferol inhibits the migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes by blocking activation of the MAPK pathway. Int Immunopharmacol, 2018, 55(2): 174-182

[20] Song G, Feng T, Zhao R, et al.. CD109 regulates the inflammatory response and is required for the pathogenesis of rheumatoid arthritis. Ann Rheum Dis, 2019, 78(12): 1632-1641

[21] Liu C, Liu H, Lu C, et al.. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model. Clin Exp Immunol, 2019, 198(3): 403-415

[22] Lin L, Gu X, Chen L, et al.. Study on the alleviation of Fengshi Gutong capsule on rheumatoid arthritis through integrating network pharmacology and experimental exploration. J Ethnopharmacol, 2021, 280(22): 114471

[23] Liu Z, Yao X, Sun B, et al.. Pretreatment with kaempferol attenuates microglia-mediate neuroinflammation by inhibiting MAPKs-NF-kappaB signaling pathway and pyroptosis after secondary spinal cord injury. Free Radic Biol Med, 2021, 168(5): 142-154

[24] Al-Khayri JM, Sahana GR, Nagella P, et al.. Flavonoids as Potential Anti-Inflammatory Molecules: A Review. Molecules, 2022, 27(9): 2901

[25] Mansour AA, Raucci F, Saviano A, et al.. Galectin-9 Regulates Monosodium Urate Crystal-Induced Gouty Inflammation Through the Modulation of Treg/Th17 Ratio. Front Immunol, 2021, 12(11): 762016

[26] Fu LQ, Yang X, Cai MH, et al.. Role of Treg/Th17 Imbalance, Microbiota and miRNAs in Pancreatic Cancer: Therapeutic Options. Crit Rev Immunol, 2020, 40(1): 75-92

[27] Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet, 2017, 389(10086): 2338-2348

[28] Zhu H, Lin Y, Liu Y. miR-34a increases inflammation and oxidative stress levels in patients with necrotizing enterocolitis by downregulating SIRT1 expression. Mol Med Rep, 2021, 24(3): 664

[29] Deng Q, Ma L, Chen T, et al.. NF-kappaB 1-induced LINC00665 regulates inflammation and apoptosis of neurons caused by spinal cord injury by targeting miR-34a-5p. Neurol Res, 2021, 43(5): 418-427

[30] Dong Y, Yang C, Pan F. Post-Translational Regulations of Foxp3 in Treg Cells and Their Therapeutic Applications. Front Immunol, 2021, 12(4): 626172

[31] Xie M, Wang J, Gong W, et al.. NF-kappaB-driven miR-34a impairs Treg/Th17 balance via targeting Foxp3. J Autoimmun, 2019, 102(8): 96-113

RIGHTS & PERMISSIONS

Huazhong University of Science and Technology